Corindus Vascular Robotics

[PRIVATE]

Service & Cobot Robotics · HQ: USA, · 1 model registered

As of Sep 2026, DEPLOY verifies Corindus Vascular Robotics: 1 model, $300.0M raised. 3 sources back the record.

Ownership

PRIVATE

Capital / Funding

$300M

Headquarters

USA,

IP / Patents

2 Active

Platform Models

1

Audited Incidents

0

Overview

Robotic vascular intervention company. Acquired by Siemens healthineers for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.

Audited Posture AssessmentPeer Percentile: 20.3%

Thin IP estate relative to category peers.

  • SURGICAL

Key Facts

ProductCorPath — FDA-cleared robotic vascular intervention platform
AcquisitionSiemens Healthineers ~$1.1B (2019)
Total Funding$100M+ pre-acquisition
StatusAcquired — now Siemens Healthineers Corindus

Safety & Regulatory Posture

0 entries
Audited Incident & Recall Footprint

No incidents on record for Corindus Vascular Robotics.

Leadership & Founders

0 entries

Key Former Leadership (1 Tracked)

Mark TolandCEO

Partnerships & Commercial Deployments

0 entries
Total Tracked0
Operating0
Announced0
Concluded0

Patents & Intellectual Property

2 entries
Active IP Portfolio (2 Filings Tracked)
  • US7646161B2[granted]uspto
    Filed: Mar 15, 2006Granted: Jan 12, 2010
  • US7689320B2[granted]uspto
    Filed: Mar 15, 2006Granted: Mar 30, 2010

Platform Models

1 entry

Sectors & Applications

1 entry

FAQ

11 entries
What is Corindus Vascular Robotics?

Robotic vascular intervention company. Acquired by Siemens healthineers for ~$1.1B (2019). Product: CorPath system — first FDA-cleared robotic-assisted vascular intervention platform. Enabled remote-controlled precision for PCI, peripheral vascular, and neurovascular procedures. $100M+ total raised before acquisition.

What does Corindus Vascular Robotics make?

Corindus Vascular Robotics has 1 robot model on the DEPLOY registry: CorPath GRX (Corindus Vascular Robotics builds physical robots).

Is Corindus Vascular Robotics publicly traded?

Corindus Vascular Robotics is not an independent public company; it has been acquired, per the DEPLOY registry.

Who is the CEO of Corindus Vascular Robotics?

Mark Toland is the ceo of Corindus Vascular Robotics, per the DEPLOY registry.

How can I invest in Corindus Vascular Robotics?

Corindus Vascular Robotics has no separately traded stock; it has been acquired.

Where is Corindus Vascular Robotics headquartered?

Corindus Vascular Robotics is headquartered in USA.

How much funding has Corindus Vascular Robotics raised?

Corindus Vascular Robotics has raised approximately $300M in disclosed funding on record in the DEPLOY registry.

Who owns Corindus Vascular Robotics?

Corindus Vascular Robotics has been acquired and is no longer independently owned.

Where does Corindus Vascular Robotics operate robots?

Corindus Vascular Robotics is a robot manufacturer and does not directly operate deployments on the DEPLOY registry. Its products are deployed by customer operators; see the company page for the verified deployment record.

Is Corindus Vascular Robotics a top robotics company?

On DEPLOY's intelligence score, which blends verified deployments, funding, hiring, media, safety, and IP signals, Corindus Vascular Robotics ranks in roughly the top 80% of companies tracked by the registry.

Is Corindus Vascular Robotics safe?

Corindus Vascular Robotics has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.